Streetbeat News

Stock Prices

HUMA

Humacyte, Inc. is facing a class action lawsuit for alleged securities law violations. The Schall Law Firm is urging impacted investors to contact them before January 17, 2025. The lawsuit pertains to securities purchased between May 10, 2024, and October 17, 2024.

Portfolio Pulse from

January 09, 2025 | 4:45 pm

ASML

Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against ASML Holding N.V. for alleged violations of the Securities Exchange Act of 1934. Investors who purchased ASML shares between January 24, 2024, and October 15, 2024, have until January 13, 2025, to seek lead plaintiff status.

Portfolio Pulse from

January 09, 2025 | 4:45 pm

CPRI

Capri Holdings Limited is facing a class action lawsuit with a lead plaintiff deadline set for February 21, 2025. Investors who suffered losses are encouraged to seek potential recovery under federal securities laws.

Portfolio Pulse from

January 09, 2025 | 4:45 pm

ASPI

Levi & Korsinsky has notified investors of ASP Isotopes Inc. (NASDAQ:ASPI) about a class action lawsuit and an upcoming deadline. Investors who suffered losses can learn about potential recovery under federal securities laws.

Portfolio Pulse from

January 09, 2025 | 4:30 pm

ASML

A class action lawsuit has been filed against ASML Holding N.V. (NASDAQ:ASML) for potential securities law violations. Investors who suffered losses are encouraged to join the suit by January 13, 2025.

Portfolio Pulse from

January 09, 2025 | 4:30 pm

BOOM

DMC Global Inc. is facing a class action lawsuit for alleged securities law violations. The Schall Law Firm is urging impacted investors to contact them before February 4, 2025.

Portfolio Pulse from

January 09, 2025 | 4:30 pm

RVNC

Revance Therapeutics Inc. is facing a class action lawsuit for alleged securities law violations. Investors who bought shares between February 29, 2024, and December 6, 2024, are encouraged to contact The Schall Law Firm by March 4, 2025.

Portfolio Pulse from

January 09, 2025 | 4:30 pm

REGN

Regeneron Pharmaceuticals Inc is facing a class action lawsuit for alleged securities law violations. The Schall Law Firm is representing impacted investors who purchased securities between November 2, 2023, and October 30, 2024. Investors are encouraged to contact the firm by March 10, 2025.

Portfolio Pulse from

January 09, 2025 | 4:30 pm

PPRUY

Kering has released its half-yearly achievement report on its share quotations liquidity mandate for December 2024. The report may mention PPRUY, which is Kering's US-listed ADR.

Portfolio Pulse from

January 09, 2025 | 4:30 pm